Amiodarone is increasingly used in cardiology due to convenient dosing, low frequency
of pro-arrhythmic effects, and good short term tolerance without significant hypotension.
However, chronic use is associated with multisystem toxic side effects. We describe
a rare case of amiodarone induced blue-gray skin discoloration.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- “Blue-grey syndrome”–a rare adverse effect of amiodarone.Cor Vasa. 2018; 60: e638-e644
- Amiodarone induced “Blue man syndrome”; an unusual presentation.Heart Lung. 2020; 49: 202-203
- Dose-dependent appearance and disappearance of amiodarone-induced skin pigmentation.Clin Cardiol. 1996; 19: 592-594
Article info
Publication history
Published online: December 16, 2022
Received:
November 22,
2022
Footnotes
Funding: none.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
